Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Investigational New Drugs|September 8, 2018
Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancerLaura W Goff, Nilofer S Azad, Stacey Stein, et al.
Investigational New Drugs|November 18, 2016
A phase I trial investigating pulsatile erlotinib in combination with gemcitabine and oxaliplatin in advanced biliary tract cancersLaura W Goff, Dana B Cardin, Jennifer G Whisenant, et al.
British Journal of Cancer|April 22, 2023
Phase I/II sequencing study of azacitidine, epacadostat, and pembrolizumab in advanced solid tumorsJason J Luke, Marwan Fakih, Charles Schneider, et al.
Plos One|September 19, 2014
Thymidylate synthase genotype-directed chemotherapy for patients with gastric and gastroesophageal junction cancersLaura W Goff, Nilay Thakkar, Liping Du, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2011
Phase II study of the mitogen-activated protein kinase 1/2 inhibitor selumetinib in patients with advanced hepatocellular carcinomaBert H O'Neil, Laura W Goff, John Sae Wook Kauh, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 2021
First-in-Human PET Imaging and Estimated Radiation Dosimetry of l-[5-11C]-Glutamine in Patients with Metastatic Colorectal CancerAllison S Cohen, Joe Grudzinski, Gary T Smith, et al.
The Oncologist|January 17, 2020
Immune-Related Adverse Events and Immune Checkpoint Inhibitor Efficacy in Patients with Gastrointestinal Cancer with Food and Drug Administration-Approved Indications for ImmunotherapySatya Das, Kristen K Ciombor, Sigurdis Haraldsdottir, et al.
JAMA Network Open|January 19, 2022
External Validation of a Clinical Score for Patients With Neuroendocrine Tumors Under Consideration for Peptide Receptor Radionuclide TherapySatya Das, Aman Chauhan, Liping Du, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2026
A phase 2 multicenter trial of rucaparib and nivolumab as maintenance therapy in patients with advanced biliary tract cancer: BilT-02Arathi Mohan, Kent A Griffith, Laura W Goff, et al.
Cancer|August 28, 2019
Second-line chemotherapy in advanced biliary cancers: A retrospective, multicenter analysis of outcomesMaeve A Lowery, Laura W Goff, Bridget P Keenan, et al.
Pageof 4